1. Babar M, Shan M. Significance of combo chelation therapy over mono chelation therapy in patient with thalassemia. Journal of Pharmaceutical Sciences and Research. 2010; 2(12): 837-43.
2. Ischemia modified albumin: An oxidative stress marker in β-thalassemia major
3. Evaluation of the Children With β-Thalassemia in Terms of Their Self-concept, Behavioral, and Parental Attitudes
4. Azami M, Parizad N, Sayehmiri K. Prevalence of hypothyroidism, hypoparathyroidism and thefrequency of regular chelation therapy in patients with thalassemia major in Iran: a systematic review and meta-analysis study. Iranian Journal of Pediatric Hematology and Oncology. 2016 Nov 10;6(4):261-76.
5. Madmoli Y, Beiranvand R, Korkini N, Mashalchi H, Karimi H, Madmoli M. Comparison of health-related quality of life in beta thalassemia major and healthy people in Dezful in 2015. Iranian Journal of Nursing Research. 2016 Apr 10;11(1):9-16.